Aurobindo Pharma Limited — Others, 06-06-2025: Action(s) taken or orders passed

Aurobindo Pharma has received an adverse order from CESTAT Chennai regarding customs duty demands linked to alleged non-fulfillment of export obligations under two Advance Authorizations. The disputed amounts include Customs duty of Rs. 29.17 lakh, redemption fine of Rs. 50 lakh, and penalty of Rs. 10 lakh. The company maintains it substantially met obligations despite delays and plans to challenge the order in the High Court. This ruling does not materially affect Aurobindo’s financials or business operations.